Signostics Closes Follow-On Financing of US$4 Million, Expands Board of...(td senior roles with Pharmacia AB in Swe...)

Amanda Heyworth is CEO of Playford Capital, serves on the board of several other organizations, co-founded a software company, taught marketing for the Australian Graduate School of Management and worked in strategy roles at the Australian Stock Exchange and the Wallis Inquiry into the Financial System.

Des Masters has had a 32-year career in banking in Australia, including several years responsible in corporate banking managing a portfolio of over $3 billion. Since retiring from corporate banking, Mr. Masters has been active in government and university assistance programs including managing the University of Adelaide's enterprise education programs.

David Shaw has worked in the medical device industry for 15 years and is presently affiliated with Monterey Advisors, Inc., a management, operations and investment consulting firm focused exclusively on medical technologies. Prior to Monterey Advisors, Mr. Shaw served for five years as Vice President, Legal Affairs and General Counsel of Kyphon Inc., a NASDAQ-traded medical device company focused on minimally invasive spinal therapies that was sold to Medtronic, Inc. in 2007 for $4.2 billion. Before Kyphon, Mr. Shaw held various senior legal positions at Intuitive Surgical, Inc., a medical robotics company.

Signostics was established in Adelaide, Australia in 2005 and expanded into the U.S. in 2008, dedicated to developing fast and affordable point-of-care medical devices. The company launched its first product into the veterinarian market in January 2009 and gained regulatory approvals to enter the human medical device market for the United States, Europe, and Australia in May 2009. Signostics has offices in Palo Alto, California and Adelaide, South Australia.